| pubmed-article:18087660 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C0246719 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C0332177 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C0439228 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:18087660 | lifeskim:mentions | umls-concept:C1707491 | lld:lifeskim |
| pubmed-article:18087660 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:18087660 | pubmed:dateCreated | 2008-6-2 | lld:pubmed |
| pubmed-article:18087660 | pubmed:abstractText | Postmenopausal women with osteoporosis received 75 mg risedronate on two consecutive days each month or 5 mg daily for 12 months. Changes in bone mineral density and bone turnover markers were similar between treatments. Risedronate 75 mg twice monthly was effective and safe suggesting a new, convenient dosing schedule. | lld:pubmed |
| pubmed-article:18087660 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18087660 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18087660 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18087660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18087660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18087660 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18087660 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18087660 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18087660 | pubmed:issn | 0937-941X | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:ReckerR RRR | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:McClungM RMR | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:Tlustochowicz... | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:DelmasP DPD | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:OlszynskiW... | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:BenhamouC LCL | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:MaiUU | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:MatzkinEE | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:EusebioRR | lld:pubmed |
| pubmed-article:18087660 | pubmed:author | pubmed-author:ZanchettaJJ | lld:pubmed |
| pubmed-article:18087660 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18087660 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:18087660 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18087660 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18087660 | pubmed:pagination | 1039-45 | lld:pubmed |
| pubmed-article:18087660 | pubmed:dateRevised | 2010-5-10 | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:meshHeading | pubmed-meshheading:18087660... | lld:pubmed |
| pubmed-article:18087660 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18087660 | pubmed:articleTitle | Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results. | lld:pubmed |
| pubmed-article:18087660 | pubmed:affiliation | University of Lyon and INSERM Research Unit 831, Lyon, France. delmas@lyon.inserm.fr | lld:pubmed |
| pubmed-article:18087660 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18087660 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18087660 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:18087660 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18087660 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18087660 | lld:pubmed |
